DDX3Y and chronic myelogenous leukemia, BCR-ABL1 positive: Table 3 describes this critical analysis of the mRNAs and lncRNAs selected from RNAseq for the validation cohort. Additionally, three lncRNAs (MALAT, HOTAIR, and Ddx3y) that did not show a statistical difference in RNAseq results but are correlated with oncohematological diseases (though not yet described in CML) according to scientific literature were included.